Jove
Visualize
Contact Us

Related Experiment Videos

Doxorubicin in sterically stabilized liposomes

D D Lasic

    Nature
    |April 11, 1996
    PubMed
    Summary

    Enhanced liposome stability and drug retention boost the anticancer effects of doxorubicin, improving chemotherapy effectiveness and potentially lowering toxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sterically stabilized liposomes in cancer therapy and gene delivery.

    Current opinion in molecular therapeutics·2001
    Same author

    Spontaneous vesiculation.

    Advances in colloid and interface science·2001
    Same author

    New directions in liposome gene delivery.

    Molecular biotechnology·1999
    Same author

    Novel applications of liposomes.

    Trends in biotechnology·1998
    Same author

    Improved DNA: liposome complexes for increased systemic delivery and gene expression.

    Nature biotechnology·1997
    Same author

    Colloid chemistry. Liposomes within liposomes.

    Nature·1997
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Pharmaceutical Sciences
    • Oncology
    • Drug Delivery Systems

    Background:

    • Doxorubicin is a widely used chemotherapy drug with significant toxicities.
    • Liposomal formulations aim to improve doxorubicin's therapeutic index.
    • Challenges remain in achieving optimal liposome stability and drug retention.

    Purpose of the Study:

    • To investigate the impact of improved liposome stability and drug retention on doxorubicin's anticancer activity.
    • To evaluate the potential of enhanced liposomal doxorubicin in reducing chemotherapy-related toxicity.

    Main Methods:

    • Formulation of doxorubicin-loaded liposomes with enhanced stability and retention characteristics.
    • In vitro and in vivo studies to assess anticancer efficacy and toxicity profiles.
    • Pharmacokinetic and pharmacodynamic analyses.

    Main Results:

    • Improved liposome stability and drug retention were achieved.
    • Enhanced liposomal doxorubicin demonstrated significantly increased anticancer activity compared to conventional doxorubicin.
    • Reduced systemic toxicity was observed with the enhanced formulation.

    Conclusions:

    • Improved liposome stability and drug retention are critical for maximizing doxorubicin's anticancer efficacy.
    • Enhanced liposomal doxorubicin represents a promising strategy for more effective and less toxic chemotherapy.
    • Further clinical investigation is warranted.

    Related Experiment Videos